Study of clinical indications of lobe-specific mediastinal lymph node dissection in patients with non-small-cell lung cancer of cTNM-Ⅰ stage
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective: At present, there are few studies on the metastasis model of mediastinal lymph node (MLN) in stage I non-small-cell lung cancer (NSCLC). This study aimed to identify if patients with different clinical characteristics have different changes in metastatic rates between lobe-specific and non-specific MLN stations in patients with preoperative stage I NSCLC, so as to predict clinical indications of lobe-specific MLN dissection in patients with preoperative stage I NSCLC. Methods: We examined 609 patients with clinical stage I NSCLC for lobectomy with complete MLN dissection. We analyzed the metastatic rates of lobe-specific and other MLN stations with patient characteristics, including T stage, tumor histology, gender and age. Results: It was revealed that metastasis was limited to lobe-specific MLNs for stage Ⅰ patients meeting the following criteria: ①male, > 60 years, squamous cell tumor, and tumor≤5cm. ②male, ≤60 years, squamous cell tumor, and tumor≤ 3 cm. ③female, squamous cell tumor, and tumor≤3 cm. ④adenocarcinoma and tumor≤2 cm. Conclusion: Lobe-specific mediastinal lymph node MLN dissection is suitable for the patients with characteristics mentioned above. For other patients, there was a considerable increasing risk of metastasis, and complete MLN dissection remains the most effective method.

    Reference
    Related
    Cited by
Get Citation

葛鹏飞,赵 飞,周 悦,李 俊,孙云刚,孟阳春,黄陈军,王 伟. cTNM-Ⅰ期非小细胞肺癌肺叶特异性纵隔淋巴结转移规律的探讨[J].南京医科大学学报(自然科学版英文版),2017,(6):714-718,736.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 08,2016
  • Revised:
  • Adopted:
  • Online: June 30,2017
  • Published:
Article QR Code